Menu

依普利酮价格多少一盒?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

In 2002, eplerenone (alias: Planep, Inspra) was first marketed in the United States. It is mainly used clinically to treat hypertension. In 2003, the FDA approved eplerenone for the treatment of heart failure after acute myocardial infarction.

The launch of eplerenone is of great significance for patients with hypertension to control hypertension, prevent cardiovascular diseases related to target organ damage, and improve the prognosis of patients with hypertension. How much does a box of eplerenone cost?

Price of eplerenone: It is understood that the price of eplerenone abroad is relatively high, and many patients cannot bear the cost for a long time. What is worth telling everyone is that a box of 50mg × 100 tablets of eplerenone from India's Lupine Pharmaceuticals costs about $500. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices.

Eplerenone is a new type of selective aldosterone receptor blocker that has minimal interaction with androgen and progesterone receptors. It has a long half-life and can effectively control hypertension, reduce damage to target organs such as the heart, brain and kidneys, and improve microalbuminuria in patients with type 2 diabetes. Its side effect rate is similar to placebo and is well tolerated.

Eplerenone usage and dosage:

1. Congestive heart failure after acute myocardial infarction: The recommended dose is 50 mg/time, once/day. The initial dose should be 25 mg/time, once/day, and within 4 weeks, the dose should be gradually increased to 50 mg/time, once/day if the patient tolerates it.

2. Anti-hypertensive: Eplerenone can be used alone or in combination with other anti-hypertensive drugs. The recommended initial dose for use alone is 50mg/time, once/day. Obvious pressure-reducing effect will appear within four weeks of taking the medicine. If the pressure effect is not obvious, it can be increased to 50mg/time, 2 times/day. Higher dosages are not recommended, otherwise there is an increased risk of adverse reactions such as hyperkalemia.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。